Additional information
| Active substance | Human Growth Hormone |
|---|---|
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Hormone levels (LH, FSH) |
| Also known as | GnRH agonist implant |
| WAREHOUSE | International Warehouse 3 |
| Blood pressure | No significant effects |
| Trade name | Suprelorin, Ovuplant |
| Storage conditions | Store at controlled room temperature, protect from light |
| Chemical name | Deslorelin acetate |
| Formula | C64H83N17O12В·C2H4O2 |
| Substance class | Gonadotropin-releasing hormone agonist (GnRH agonist) |
| Main action | Increases the production of gonadotropins |
| Half-life | 2-3 hours |
| Dosage (medical) | Typically, 2.1 mg implant every 6 months |
| Dosage (sports) | Not applicable |
| Effects | Induces a temporary decrease in gonadotropin secretion |
| Side effects | Local injection site reactions, altered testosterone levels, potential bone density reduction |
| Use in sports | Not typically used or recommended in sports |
| Manufacturer | Beligas |
Zimaks 400 Bilim
Seretide Disckus (Advair) 250 mcg Glaxosmithkline
FUCIDIN 500 mg Abdi Ibragim
Clenbuterol 40 Maha Pharma
Champix 56 tabs Pfizer
Norvacs 10 mg Pfizer 

Reviews
There are no reviews yet.